Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic CRC, gastric cancer (GC), SCCHN, or other tumors.
Josep Tabernero
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Onyx; Pfizer; Roche; Sanofi
Honoraria - Amgen; Merck KGaA; Novartis; Roche; Sanofi
John D. Powderly
Employment or Leadership Position - BioCytics
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Roche/Genentech
Stock Ownership - BioCytics
Honoraria - Bristol-Myers Squibb; Dendreon; Genentech
Research Funding - Amplimmune; Bristol-Myers Squibb; Genentech/Roche; ImClone Systems; Lilly; Millennium; Progenics; Regeneron
Other Remuneration - Genentech
Omid Hamid
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Michael S. Gordon
Consultant or Advisory Role - Genentech
Research Funding - Genentech
George A. Fisher
Research Funding - Genentech
Fadi S. Braiteh
Consultant or Advisory Role - Agendia
Honoraria - Amgen; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Dendreon; Genomic Health; INSYS; Myriad Genetics; Pfizer
Research Funding - Bayer; Genentech; GlaxoSmithKline; Merrimack; Myriad Genetics; Onyx; Pfizer
Lawrence E. Garbo
No relevant relationships to disclose
Gregg Daniel Fine
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Marcin Kowanetz
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Bruce McCall
Employment or Leadership Position - Genentech
Xiaodong Shen
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche
Daniel S. Chen
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Holbrook Edwin Kohrt
No relevant relationships to disclose